ArticleRSC chemical biology2026
Guanine base modifications in antisense oligonucleotides mitigate acute central nervous system toxicity.
Maho Katsuyama, Taiki Matsubayashi, Yang Ying, Su Su Lei Mon, Takayuki Kuroda, Kie Yoshida-Tanaka, Rintaro Iwata Hara, Takeshi Yamada, Kumiko Ui-Tei, Kotaro Yoshioka
Abstract read
In one paragraphArticle in RSC chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Maho KatsuyamaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.
Taiki MatsubayashiDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.
Yang YingDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.
Su Su Lei MonDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.
Takayuki KurodaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.
Kie Yoshida-TanakaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.
Rintaro Iwata HaraDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.ORCID https://orcid.org/0000-0003-2399-3431 Takeshi YamadaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.ORCID https://orcid.org/0000-0003-3275-415X Kumiko Ui-TeiCenter for Brain Integration Research, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 Tokyo Japan.
Kotaro YoshiokaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo 1-5-45 Yushima, Bunkyo-Ku Tokyo 113-8519 Japan kotanuro@md.isct.ac.jp.ORCID https://orcid.org/0000-0001-7094-9017 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Antisense oligonucleotides (ASOs) are recognized as promising therapeutic agents for central nervous system (CNS) diseases. However, neurotoxicity induced by ASOs
Identifiers
PMID41928909
PMCPMC13040562
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390